The present disclosure provides a method of using meloxicam to provide analgesia or control inflammation in sheep wherein the method comprises administering the sheep a therapeutically effective amount of a formulation containing pharmacologically acceptable meloxicam or meloxicam salt. More preferably the method involves administering it to sheep undergoing a painful surgical procedure including one or more of: (i) tail docking, (ii) castration, (iii) muiesing. The formulations provided are adapted for administration via the oral and buccal route and preferably administered to the sheep is in the range of 0.25mg/kg to 1.Omg/kg of bodyweight of the sheep. The formulations provided have a concentration of meloxicam or meloxicam salt between 0.25% and 1 % (w/v) which when administered, result in a C max plasma concentration of meloxicam in the sheep of at least 750 mg/ml. The formulations provided include liquid gels, liquid suspensions and liquid solutions.
